المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/journal_contribution/Prisma_checklist_for_reporting_systematic_reviews_/25409701

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.s001

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/dataset/Supporting_information_including_the_data_extraction_Excel_file_the_quality_assessment_scoring_sheet_and_the_Review_Manager_software_file_/25409704

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.s002

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/figure/Forest_plot_for_pain_scores_on_VAS_0_10_/25409716

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.g004

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/figure/The_risk_of_adverse_events_/25409719

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.g005

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/dataset/Search_string_/25409722

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.t001

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/figure/Risk_of_bias_graph_/25409710

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.g002

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/figure/Risk_of_bias_summary_/25409713

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.g003

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/figure/PRISMA_flowchart_showing_the_study_selection_process_/25409707

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.g001

المؤلفون: Ravinder S. Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H. Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan

مصطلحات موضوعية: Biotechnology, Cancer, Science Policy, maximum occlusal force, maximum mouth opening, 54 &# 8211, 48 &# 8211, secondary outcomes evaluated, utilizing botulinum toxin, rob 2 tool, manage temporomandibular disorders, 3 months respectively, +btx%22">xlink "> btx, analysis , placebo group showed, %22">xlink ">, temporomandibular disorders, botulinum toxin, &# 8722, btx group, better outcomes, three months, six months, statistically significant, statistically insignificant, sixty non, significantly better, side effects, risk ratio, relative risk

Relation: https://figshare.com/articles/dataset/Study_descriptor_table_/25409725

الاتاحة: https://doi.org/10.1371/journal.pone.0300157.t002